Cargando…

PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis

PARP1 has been shown to regulate EBV latency. However, the therapeutic effect of PARP1 inhibitors on EBV+ lymphomagenesis has not yet been explored. Here, we show that PARPi BMN-673 has a potent anti-tumor effect on EBV-driven LCL in a mouse xenograft model. We found that PARP1 inhibition induces a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Napoletani, Giorgia, Soldan, Samantha S., Kannan, Toshitha, Preston-Alp, Sarah, Vogel, Peter, Maestri, Davide, Caruso, Lisa Beatrice, Kossenkov, Andrew, Sobotka, Asher, Lieberman, Paul M., Tempera, Italo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350008/ https://www.ncbi.nlm.nih.gov/pubmed/37461649 http://dx.doi.org/10.1101/2023.07.05.547847

Ejemplares similares

Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer
por: Preston-Alp, Sarah, et al.
Publicado: (2023)

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes
por: Su, Chenhe, et al.
Publicado: (2021)

Three-Dimensional Chromatin Structure of the EBV Genome: A Crucial Factor in Viral Infection
por: Caruso, Lisa Beatrice, et al.
Publicado: (2023)

The nuclear lamina binds the EBV genome during latency and regulates viral gene expression
por: Caruso, Lisa Beatrice, et al.
Publicado: (2022)

EBV Latency Types Adopt Alternative Chromatin Conformations
por: Tempera, Italo, et al.
Publicado: (2011)

EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells
por: Lu, Fang, et al.
Publicado: (2014)

Interpreting the Epstein-Barr Virus (EBV) Epigenome Using High-Throughput Data
por: Arvey, Aaron, et al.
Publicado: (2013)

CTCF Prevents the Epigenetic Drift of EBV Latency Promoter Qp
por: Tempera, Italo, et al.
Publicado: (2010)

The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity
por: Morgan, Sarah M., et al.
Publicado: (2022)

The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency
por: Styles, Christine T., et al.
Publicado: (2018)

Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis
por: Bhattacharjee, Shaoni, et al.
Publicado: (2016)

Targeted disruption of EBNA1 in EBV-infected cells attenuated cell growth
por: Noh, Ka-Won, et al.
Publicado: (2016)

BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
por: Paschos, Kostas, et al.
Publicado: (2012)

EBV persistence without its EBNA3A and 3C oncogenes in vivo
por: Murer, Anita, et al.
Publicado: (2018)

Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children
por: Ai, Junhong, et al.
Publicado: (2012)

EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells
por: Huo, Shaofen, et al.
Publicado: (2020)

PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice
por: Zhang, Xiang, et al.
Publicado: (2021)

Regulation of EBNA1 protein stability and DNA replication activity by PLOD1 lysine hydroxylase
por: Dheekollu, Jayaraju, et al.
Publicado: (2023)

A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism
por: Lamontagne, R. Jason, et al.
Publicado: (2021)

PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type
por: Lupey-Green, Lena N., et al.
Publicado: (2018)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation
por: Jha, Hem Chandra, et al.
Publicado: (2015)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Oncogenic Viruses as Entropic Drivers of Cancer Evolution
por: Tempera, Italo, et al.
Publicado: (2021)

Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV
por: Bazot, Quentin, et al.
Publicado: (2018)

Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells
por: Soldan, Samantha, et al.
Publicado: (2023)

Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
por: Hertle, Marie L., et al.
Publicado: (2009)

Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival
por: Bhattacharjee, Shaoni, et al.
Publicado: (2018)

Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a “Bookmarking” Oncoprotein that Alters the Host Cell Epigenotype?
por: Niller, Hans Helmut, et al.
Publicado: (2012)

Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes
por: Soldan, Samantha S., et al.
Publicado: (2021)

EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1
por: Lu, Fang, et al.
Publicado: (2016)

EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency
por: Klein, Eva, et al.
Publicado: (2013)

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter
por: Lupey-Green, Lena N., et al.
Publicado: (2017)

Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
por: AlQarni, Sana, et al.
Publicado: (2018)

Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families
por: Chang, C M, et al.
Publicado: (2012)

Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib
por: Hui, Kwai Fung, et al.
Publicado: (2018)

Poly(ADP-ribose) Polymerase 1, PARP1, modifies EZH2 and inhibits EZH2 histone methyltransferase activity after DNA damage
por: Caruso, Lisa B., et al.
Publicado: (2018)

MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
por: Massó-Vallés, Daniel, et al.
Publicado: (2022)

EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells
por: Kalchschmidt, Jens S., et al.
Publicado: (2016)

Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma from Vietnam
por: Thuan, LD, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_36dn59d050mnoud7uv9v5tu29d